GANIRELIX ACETATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ganirelix Acetate, and what generic alternatives are available?
Ganirelix Acetate is a drug marketed by Amphastar Pharms Inc, Gland Pharma Ltd, Lupin Ltd, Meitheal, and Organon Usa Organon. and is included in five NDAs.
The generic ingredient in GANIRELIX ACETATE is ganirelix acetate. There are four drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the ganirelix acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ganirelix Acetate
A generic version of GANIRELIX ACETATE was approved as ganirelix acetate by ORGANON USA ORGANON on July 29th, 1999.
Summary for GANIRELIX ACETATE
US Patents: | 0 |
Applicants: | 5 |
NDAs: | 5 |
Finished Product Suppliers / Packagers: | 6 |
Raw Ingredient (Bulk) Api Vendors: | 59 |
Clinical Trials: | 20 |
Patent Applications: | 2,590 |
Drug Prices: | Drug price information for GANIRELIX ACETATE |
What excipients (inactive ingredients) are in GANIRELIX ACETATE? | GANIRELIX ACETATE excipients list |
DailyMed Link: | GANIRELIX ACETATE at DailyMed |
Recent Clinical Trials for GANIRELIX ACETATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Yale University | N/A |
University of Wisconsin, Madison | Early Phase 1 |
Casa di Cura Privata Villa Mafalda | Phase 4 |
Pharmacology for GANIRELIX ACETATE
Drug Class | Gonadotropin Releasing Hormone Receptor Antagonist |
Mechanism of Action | Gonadotropin Releasing Hormone Receptor Antagonists |
Physiological Effect | Decreased GnRH Secretion |
Anatomical Therapeutic Chemical (ATC) Classes for GANIRELIX ACETATE
Paragraph IV (Patent) Challenges for GANIRELIX ACETATE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
GANIRELIX ACETATE | Injection | ganirelix acetate | 250 mcg/0.5 mL, 1 mL PFS | 021057 | 1 | 2012-03-30 |
US Patents and Regulatory Information for GANIRELIX ACETATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amphastar Pharms Inc | GANIRELIX ACETATE | ganirelix acetate | INJECTABLE;INJECTION | 212613-001 | Apr 7, 2022 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Meitheal | GANIRELIX ACETATE | ganirelix acetate | INJECTABLE;INJECTION | 214996-001 | Jun 6, 2022 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Gland Pharma Ltd | GANIRELIX ACETATE | ganirelix acetate | INJECTABLE;INJECTION | 215658-001 | Feb 28, 2023 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Lupin Ltd | GANIRELIX ACETATE | ganirelix acetate | INJECTABLE;INJECTION | 216075-001 | Nov 16, 2023 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Organon Usa Organon | GANIRELIX ACETATE | ganirelix acetate | INJECTABLE;INJECTION | 021057-001 | Jul 29, 1999 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for GANIRELIX ACETATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Organon Usa Organon | GANIRELIX ACETATE | ganirelix acetate | INJECTABLE;INJECTION | 021057-001 | Jul 29, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
Organon Usa Organon | GANIRELIX ACETATE | ganirelix acetate | INJECTABLE;INJECTION | 021057-001 | Jul 29, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
Organon Usa Organon | GANIRELIX ACETATE | ganirelix acetate | INJECTABLE;INJECTION | 021057-001 | Jul 29, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for GANIRELIX ACETATE
See the table below for patents covering GANIRELIX ACETATE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | S63201199 | NONAPEPTIDE OF LHRH USEFUL AS LHRH ANTAGONIST AND DECAPEPTIDE ANALOGUE | ⤷ Try a Trial |
Spain | 2247710 | ⤷ Try a Trial | |
Hungary | T63855 | ⤷ Try a Trial | |
Denmark | 57288 | ⤷ Try a Trial | |
South Africa | 8800795 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for GANIRELIX ACETATE
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0277829 | SPC/GB00/024 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: GANIRELIX OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: UK EU/1/00/130/001 20000517; UK EU/1/00/130/002 20000517 |
0277829 | 27/2000 | Austria | ⤷ Try a Trial | PRODUCT NAME: GANIRELIX ODER PHARMAZEUTISCH ANNEHMBARE SALZE DAVON; REGISTRATION NO/DATE: EU/1/00/130/001-002 20000517 |
0277829 | 2000C/030 | Belgium | ⤷ Try a Trial | PRODUCT NAME: GANIRELIX; REGISTRATION NO/DATE: EU/1/00/130/001 20000518 |
0277829 | C300016 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: GANIRELIX, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; NATL REGISTRATION NO/DATE: EU/1/00/130/001-002 20000517 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |